HUP0004037A2 - Új dihidronaftalin-származékok és eljárás az előállításukra - Google Patents
Új dihidronaftalin-származékok és eljárás az előállításukraInfo
- Publication number
- HUP0004037A2 HUP0004037A2 HU0004037A HUP0004037A HUP0004037A2 HU P0004037 A2 HUP0004037 A2 HU P0004037A2 HU 0004037 A HU0004037 A HU 0004037A HU P0004037 A HUP0004037 A HU P0004037A HU P0004037 A2 HUP0004037 A2 HU P0004037A2
- Authority
- HU
- Hungary
- Prior art keywords
- group
- inhibitory activity
- compounds
- cancer
- branched
- Prior art date
Links
- KEIFWROAQVVDBN-UHFFFAOYSA-N 1,2-dihydronaphthalene Chemical class C1=CC=C2C=CCCC2=C1 KEIFWROAQVVDBN-UHFFFAOYSA-N 0.000 title abstract 2
- 230000002401 inhibitory effect Effects 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 206010002383 Angina Pectoris Diseases 0.000 abstract 1
- 102000014654 Aromatase Human genes 0.000 abstract 1
- 108010078554 Aromatase Proteins 0.000 abstract 1
- 206010006187 Breast cancer Diseases 0.000 abstract 1
- 208000026310 Breast neoplasm Diseases 0.000 abstract 1
- 206010008342 Cervix carcinoma Diseases 0.000 abstract 1
- 201000009273 Endometriosis Diseases 0.000 abstract 1
- 206010033128 Ovarian cancer Diseases 0.000 abstract 1
- 206010061535 Ovarian neoplasm Diseases 0.000 abstract 1
- 206010060862 Prostate cancer Diseases 0.000 abstract 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 abstract 1
- 102000001854 Steroid 17-alpha-Hydroxylase Human genes 0.000 abstract 1
- 108010015330 Steroid 17-alpha-Hydroxylase Proteins 0.000 abstract 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 208000030270 breast disease Diseases 0.000 abstract 1
- 201000010881 cervical cancer Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000001419 dependent effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003163 gonadal steroid hormone Substances 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000002883 imidazolyl group Chemical group 0.000 abstract 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 abstract 1
- 208000010125 myocardial infarction Diseases 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 230000003449 preventive effect Effects 0.000 abstract 1
- 210000002307 prostate Anatomy 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- DSNBHJFQCNUKMA-SCKDECHMSA-N thromboxane A2 Chemical compound OC(=O)CCC\C=C/C[C@@H]1[C@@H](/C=C/[C@@H](O)CCCCC)O[C@@H]2O[C@H]1C2 DSNBHJFQCNUKMA-SCKDECHMSA-N 0.000 abstract 1
- 230000001018 virulence Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
- C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
A találmány kiváló 17a-hidroxiláz/C17-20-liáz gátló aktivitással,tromboxán A2 szintézis gátló aktivitással és aromatáz gátlóaktivitással rendelkező, általános képletű új dihidronaftalinvegyületekre és sóikra vonatkozik, ahol R1 hidrogénatomot,hidroxilcsoportot vagy egyenes vagy elágazó szénláncú, C1-C6alkiloxicsoportot jelent; R2 hidrogénatomot, egyenes vagy elágazószénláncú, C1-C6 alkilcsoportot, fenil- vagy aralkilcsoportot képviselés R3 jelentése piridil- vagy imidazolilcsoport. Ezek a vegyületekkülönböző férfi és női nemi hormon függő megbetegedések, mint aprosztatarák, prosztatamegnagyobbodás, elférfiasodás, mellrák,masztopátia, petefészekrák, endometriozis, méhnyakrák, valamintszívizominfarktus, angina pectoris és hörgőasztma megelőző és/vagyterápiás kezelésére használhatók. Ó
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP28426397 | 1997-10-02 | ||
PCT/JP1998/004426 WO1999018075A1 (fr) | 1997-10-02 | 1998-10-01 | Nouveaux composes a base de dihydronaphtalene et leur procede de production |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0004037A2 true HUP0004037A2 (hu) | 2001-10-28 |
HUP0004037A3 HUP0004037A3 (en) | 2002-03-28 |
Family
ID=17676271
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0004037A HUP0004037A3 (en) | 1997-10-02 | 1998-10-01 | Novel dihydronaphthalene compounds and process for producing the same |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP1028110B1 (hu) |
KR (1) | KR20000069426A (hu) |
CN (1) | CN1117732C (hu) |
AT (1) | ATE264304T1 (hu) |
AU (1) | AU743405B2 (hu) |
CA (1) | CA2298527A1 (hu) |
DE (1) | DE69823222T2 (hu) |
DK (1) | DK1028110T3 (hu) |
ES (1) | ES2218853T3 (hu) |
FI (1) | FI20000207A (hu) |
HU (1) | HUP0004037A3 (hu) |
IL (1) | IL133483A0 (hu) |
NO (1) | NO315044B1 (hu) |
NZ (1) | NZ501822A (hu) |
RU (1) | RU2203890C2 (hu) |
WO (1) | WO1999018075A1 (hu) |
ZA (1) | ZA988954B (hu) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100287366B1 (ko) | 1997-11-24 | 2001-04-16 | 윤순조 | 엠피이지 방식을 이용한 휴대용 음향 재생장치 및 방법 |
US7001926B2 (en) | 2000-03-10 | 2006-02-21 | Oxigene, Inc. | Tubulin binding agents and corresponding prodrug constructs |
TWI283669B (en) * | 1999-06-10 | 2007-07-11 | Allergan Inc | Compounds and method of treatment having agonist-like activity selective at alpha 2B or 2B/2C adrenergic receptors |
US6849656B1 (en) | 1999-09-17 | 2005-02-01 | Baylor University | Indole-containing and combretastatin-related anti-mitotic and anti-tubulin polymerization agents |
JP4616454B2 (ja) * | 1999-10-22 | 2011-01-19 | 武田薬品工業株式会社 | 1−置換フェニル−1−(1h−イミダゾール−4−イル)アルコール類、その製造法および用途 |
DE60027034T2 (de) | 1999-10-22 | 2006-11-09 | Takeda Pharmaceutical Co. Ltd. | 1-substituierte-phenyl-1-(1h-imidazol-4-yl)alkohole, verfahren zu deren herstellung sowie deren verwendung |
JP4520012B2 (ja) * | 1999-10-22 | 2010-08-04 | 武田薬品工業株式会社 | 1−置換−1−(1h−イミダゾール−4−イル)メタノール類 |
JP2004505888A (ja) | 2000-03-10 | 2004-02-26 | ベイラー・ユニバーシテイ | チューブリン結合リガンドおよび対応するプロドラッグ構造 |
US7091240B2 (en) | 2000-03-10 | 2006-08-15 | Oxigene, Inc. | Tubulin binding ligands and corresponding prodrug constructs |
MY134929A (en) | 2000-11-17 | 2008-01-31 | Takeda Pharmaceutical | Novel imidazole derivatives, production method thereof and use thereof |
ATE502030T1 (de) | 2000-11-20 | 2011-04-15 | Takeda Pharmaceutical | Imidazolderivate, verfahren zu deren herstellung und deren verwendung |
DE60139639D1 (de) | 2000-12-08 | 2009-10-01 | Takeda Pharmaceutical | Substituierte thiazolderivate mit 3-pyridylgruppen, verfahren zu deren herstellung und deren verwendung |
WO2004073602A2 (en) * | 2002-01-25 | 2004-09-02 | Pharmacia Corporation | Aldosterone blocker therapy to prevent or treat inflammation-related disorders |
US7456214B2 (en) | 2004-05-03 | 2008-11-25 | Baylor University | Chromene-containing compounds with anti-tubulin and vascular targeting activity |
UA105794C2 (uk) | 2009-06-26 | 2014-06-25 | Новартіс Аг | 1,3-ДИЗАМІЩЕНІ ПОХІДНІ ІМІДАЗОЛІДИН-2-ОНУ ЯК ІНГІБІТОРИ Cyp17 |
WO2012018948A2 (en) | 2010-08-04 | 2012-02-09 | Pellficure Pharmaceuticals, Inc. | Novel treatment of prostate carcinoma |
JP2013537210A (ja) | 2010-09-16 | 2013-09-30 | ノバルティス アーゲー | 17α−ヒドロキシラーゼ/C17,20−リアーゼ阻害剤 |
JP6002210B2 (ja) | 2011-04-28 | 2016-10-05 | ノバルティス アーゲー | 17α−ヒドロキシラーゼ/C17,20−リアーゼ阻害剤 |
EP2968219B1 (en) | 2013-03-14 | 2019-04-24 | Pellficure Pharmaceuticals, Inc. | Novel therapy for prostate carcinoma |
US10093620B2 (en) | 2014-09-12 | 2018-10-09 | Pellficure Pharmaceuticals, Inc. | Compositions and methods for treatment of prostate carcinoma |
AU2017350690A1 (en) | 2016-10-24 | 2019-06-13 | Pellficure Pharmaceuticals Inc. | Pharmaceutical compositions of 5-hydroxy-2-methylnaphthalene-1, 4-dione |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5681566A (en) * | 1979-12-05 | 1981-07-03 | Yoshitomi Pharmaceut Ind Ltd | Imidazole derivative |
ZA825413B (en) * | 1981-08-26 | 1983-06-29 | Pfizer | Thromboxane synthetase inhibitors, processes for their production, and pharmaceutical compositions comprising them |
US4540705A (en) * | 1983-03-14 | 1985-09-10 | Sterling Drug Inc. | Antidepressant imidazolines and related compounds |
PH22076A (en) * | 1983-08-25 | 1988-05-20 | Daiichi Seiyaku Co | Benzocycloalkane derivative |
JPS61186348A (ja) * | 1985-02-14 | 1986-08-20 | Dai Ichi Seiyaku Co Ltd | ナフタレン誘導体 |
DE3508905A1 (de) * | 1985-03-13 | 1986-09-18 | Hoechst Ag, 6230 Frankfurt | Neue imidazolylverbindungen und verfahren zu ihrer herstellung |
JPH06166674A (ja) * | 1992-12-01 | 1994-06-14 | Tokyo Tanabe Co Ltd | テトラリン化合物 |
JP3338905B2 (ja) * | 1993-05-13 | 2002-10-28 | 帝国臓器製薬株式会社 | 6位置換ステロイド誘導体 |
HUT75871A (en) * | 1993-09-30 | 1997-05-28 | Yamanouchi Co | Azole derivatives and pharmaceutical compositions thereof |
FR2787451B1 (fr) * | 1998-12-18 | 2001-01-26 | Adir | Nouveaux composes imidazoliniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
1998
- 1998-10-01 ES ES98945556T patent/ES2218853T3/es not_active Expired - Lifetime
- 1998-10-01 WO PCT/JP1998/004426 patent/WO1999018075A1/ja active Search and Examination
- 1998-10-01 DE DE69823222T patent/DE69823222T2/de not_active Expired - Fee Related
- 1998-10-01 AT AT98945556T patent/ATE264304T1/de not_active IP Right Cessation
- 1998-10-01 EP EP98945556A patent/EP1028110B1/en not_active Expired - Lifetime
- 1998-10-01 ZA ZA988954A patent/ZA988954B/xx unknown
- 1998-10-01 NZ NZ501822A patent/NZ501822A/en unknown
- 1998-10-01 RU RU99127323/04A patent/RU2203890C2/ru not_active IP Right Cessation
- 1998-10-01 CA CA002298527A patent/CA2298527A1/en not_active Abandoned
- 1998-10-01 IL IL13348398A patent/IL133483A0/xx unknown
- 1998-10-01 DK DK98945556T patent/DK1028110T3/da active
- 1998-10-01 KR KR1019997005209A patent/KR20000069426A/ko not_active Application Discontinuation
- 1998-10-01 AU AU92810/98A patent/AU743405B2/en not_active Ceased
- 1998-10-01 CN CN98808436A patent/CN1117732C/zh not_active Expired - Fee Related
- 1998-10-01 HU HU0004037A patent/HUP0004037A3/hu unknown
-
2000
- 2000-02-01 FI FI20000207A patent/FI20000207A/fi not_active Application Discontinuation
- 2000-03-10 NO NO20001289A patent/NO315044B1/no unknown
Also Published As
Publication number | Publication date |
---|---|
DE69823222D1 (de) | 2004-05-19 |
HUP0004037A3 (en) | 2002-03-28 |
EP1028110A1 (en) | 2000-08-16 |
FI20000207A (fi) | 2000-02-01 |
NZ501822A (en) | 2001-12-21 |
AU9281098A (en) | 1999-04-27 |
ATE264304T1 (de) | 2004-04-15 |
CN1268120A (zh) | 2000-09-27 |
CN1117732C (zh) | 2003-08-13 |
ZA988954B (en) | 1999-04-12 |
DE69823222T2 (de) | 2005-04-14 |
CA2298527A1 (en) | 1999-04-15 |
WO1999018075A1 (fr) | 1999-04-15 |
NO20001289L (no) | 2000-03-10 |
NO20001289D0 (no) | 2000-03-10 |
NO315044B1 (no) | 2003-06-30 |
EP1028110A4 (en) | 2001-05-23 |
DK1028110T3 (da) | 2004-07-19 |
ES2218853T3 (es) | 2004-11-16 |
KR20000069426A (ko) | 2000-11-25 |
IL133483A0 (en) | 2001-04-30 |
EP1028110B1 (en) | 2004-04-14 |
RU2203890C2 (ru) | 2003-05-10 |
AU743405B2 (en) | 2002-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0004037A2 (hu) | Új dihidronaftalin-származékok és eljárás az előállításukra | |
HUP0303354A2 (hu) | Gyulladásgátló hatású 6-alfa, 9-alfa-difluor-17-alfa-(2-furanilkarbonil)oxi-11-béta-hidroxi-16-alfa-metil-3-oxo-androst-1,4-dién-17-tiokarbonsav-S-fluormetil-észter, eljárás az előállítására és ezt tartalmazó gyógyszerkészítmény | |
AP1649A (en) | Triamide-substituted heterobicyclic compounds. | |
TR200103273T2 (tr) | Hemisentetik yöntem ve yeni bileşimler. | |
HUP0300080A2 (hu) | Új malonsavszármazékok, eljárás előállításukra, ezek alkalmazása Xa faktor inhibitorként és ezeket tartalmazó gyógyszerkészítmények | |
HUP0303756A2 (hu) | 1-Aril- vagy 1-alkilszulfonil-heterociklobenzazolok és eljárás ezek elõállítására és ezeket tartalmazó gyógyszerkészítmények | |
HK1089444A1 (en) | Dihydropteridinones, method for the production and use thereof in the form of drugs | |
YU82802A (sh) | Antranilamidi i njihova primena kao sredstva za lečenje | |
TW200407320A (en) | Macrocyclic compounds useful as pharmaceuticals | |
MXPA04006266A (es) | Pirimidotriazinas como inhibidores de fosfatasa. | |
HUP0200580A2 (hu) | Celecoxib polimorf kristályos formái, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
ZA200404752B (en) | 6-aminomorphinane derivatives method for the production and use thereof | |
WO2003106450A8 (de) | Phenylaminopyrimidine und ihre verwendung als rho-kinase inhibitoren | |
HUP0401014A2 (hu) | Eljárás 7-amino-szin-3,5-dihidroxi-heptánsavszármazékok előállítására, 6-ciano-szin-3,5-dihidroxi-hexánsav származékokon keresztül | |
NZ543632A (en) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
HUP9802764A2 (hu) | Guanidino-proteáz-inhibitorok | |
YU76500A (sh) | Hemijska sinzeza morfolinskih derivata | |
HUP0402033A2 (hu) | 2-Amino-4-piridil-metil-tiazolin-származékok alkalmazása az indukálható NO-szintetáz inhibitoraként, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
HUP9801056A2 (hu) | Apolipoprotein-B szintézist gátló triazolonszármazékok, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények | |
TR200504091T2 (tr) | (7alfa,17alfa)-17-hidroksi-7-metil-19-nor-17-pregn-5(10)-en 20-in-3-on içeren yüksek saflıkta bileşim. | |
DK1347965T3 (da) | Hidtil ukendte desloratidinsalte, fremgangsmåde til syntese deraf samt farmaceutiske præparater deraf | |
HUP0302121A2 (hu) | {[(Biciklil- vagy heterobiciklil-metil)-szulfonil]-alkil}-csoporttal szubsztituált N-hidroxi-formamidok, eljárás előállításukra, intermedierek és a vegyületeket tartalmazó gyógyszerkészítmények | |
DE502004003212D1 (de) | Verbindungen, die faktor viia inhibieren | |
HUP0401912A2 (hu) | A 20(S) camptotecinek gyógyszerészetileg elfogadható sói, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
HUP0401921A2 (hu) | Közbenső termékek mirtazapin előállítására és az előállításukra szolgáló eljárások |